Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

Radiofrequency ablation (or RFA) is a procedure that can ease chronic pain for some people. The procedure uses radio waves that produce electrical currents. These currents heat and kill a small ...

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

Autonomix Medical (Nasdaq:AMIX) announced today that it filed to effect a 1-for-20 reverse stock split of its common stock.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...

The evolving landscape of musculoskeletal interventional oncology treatment for the management of painful bone metastases.

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

Radiofrequency ablation is a common therapeutic modality to treat various types of chronic pain. The use of facet median nerve branch radiofrequency ablation (RFA) for cervical, thoracic and ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Radiofrequency ablation offers the advantage of being precise, reproducible and effective to a great extent. It also has the ability to stimulate before the ablation to avoid ablating the wrong ...